Tags : Joins

Oxford Biomedica Joins Consortium to Develop ChAdOx1 nCov-19 for COVID-19

Shots: Oxford Biomedica has joined the consortium, which is led by the Jenner Institute, University of Oxford and also includes the VMIC, Pall Life Sciences, Cobra Biologics, and Halix BV to rapidly develop, scale-up and manufacture a vaccine (ChAdOx1 nCov-19) against COVID-19 The ChAdOx1 nCOV-19 vaccine is anticipated to be the UK’s first COVID-19 vaccine […]Read More